but unlike the mrna vaccines we ve come to know, at duke they re working on something called a nanoparticle vaccine. there s multiple sites that can be recognized by antibodies. think of it like a soccer ball with tiny proteins stuck to the surface, each with a key site of the protein. so far in primates the vaccine seems to work. and now a similar vaccine prepared pie military scientists has made it into human trials. but as exciting as this science is, it s going t take time and patience. i don t think anyone to think that pan coronavirus vaccines are literally around the cornner a month or two. it s going to take years to develop. much of the work being done today on covid is built on the back of similar research on other viruses. f influenza, hiv. we ve been working on an hiv vaccine now almost 30 years here
First authorization of Novavax' COVID-19 vaccine in adolescent population receivedCovovax (SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine) is the first protein-based
Howard Hughes Medical Institute (HHMI) Investigator David Veesler and his team at the University of Washington have been in the lab day and night scrutinizing people’s immune responses to SARS-CoV-2 and its variants, designing new coronavirus vaccines, and sharing their insights with colleagues in the US and abroad.